All Stories

  1. Computational and Experimental Binding Interactions of Drug and β-Cyclodextrin as a Drug- Delivery Vehicle
  2. Ion Channels as Therapeutic Targets for Type 1 Diabetes Mellitus
  3. Computational and Experimental Binding Mechanism of DNA-drug Interactions
  4. Exploring the biology and structural architecture of sortase roleon Biofilm formation in gram positive pathogens
  5. Molecular dynamics simulations and applications in computational toxicology and nanotoxicology
  6. Protein Engineering Approaches in the Post-Genomic Era
  7. Advantages of Structure-Based Drug Design Approaches in Neurological Disorders
  8. Development of estrogen receptor beta binding prediction model using large sets of chemicals
  9. Chemopreventive effect of saponin isolated from Gymnema sylevestre on prostate cancer through in silico and in vivo analysis
  10. Modeling of macromolecular proteins in prophenoloxidase cascade through experimental and computational approaches
  11. Phytoremediation of metal-contaminated soils by the hyperaccumulator canola ( Brassica napus L.) and the use of its biomass for ethanol production
  12. Structural insights into the binding mode of d-sorbitol with sorbitol dehydrogenase using QM-polarized ligand docking and molecular dynamics simulations
  13. Consensus Modeling for Prediction of Estrogenic Activity of Ingredients Commonly Used in Sunscreen Products
  14. A highly efficient sorbitol dehydrogenase from Gluconobacter oxydans G624 and improvement of its stability through immobilization
  15. Potential of Immobilized Whole-Cell Methylocella tundrae as a Biocatalyst for Methanol Production from Methane
  16. Enhancement of methanol production from synthetic gas mixture by Methylosinus sporium through covalent immobilization
  17. Understanding the importance of conservative hypothetical protein LdBPK_070020 in Leishmania donovani and its role in subsistence of the parasite
  18. In vitro and in silico studies on cell adhesion protein peroxinectin from Fenneropenaeus indicus and screening of heme blockers against activity
  19. Structure-Based Virtual Screening and Biological Evaluation of a Calpain Inhibitor for Prevention of Selenite-Induced Cataractogenesis in an in Vitro System
  20. Molecular insights of protein contour recognition with ligand pharmacophoric sites through combinatorial library design and MD simulation in validating HTLV-1 PR inhibitors
  21. Mechanistic insights of SrtA–LPXTG blockers targeting the transpeptidase mechanism in Streptococcus mutans
  22. Explicit Drug Re-positioning
  23. Molecular cloning, relative expression, and structural analysis of pattern recognition molecule β-glucan binding protein from mangrove crabEpisesarma tetragonum
  24. Molecular insights on analogs of HIV PR inhibitors toward HTLV-1 PR through QM/MM interactions and molecular dynamics studies: comparative structure analysis of wild and mutant HTLV-1 PR
  25. In Silico and In Vitro Studies on the Protein-Protein Interactions between Brugia malayi Immunomodulatory Protein Calreticulin and Human C1q
  26. Examine the characterization of biofilm formation and inhibition by targeting SrtA mechanism in Bacillus subtilis: a combined experimental and theoretical study
  27. Communication of γ Phage Lysin plyG Enzymes Binding toward SrtA for Inhibition ofBacillus Anthracis: Protein–Protein Interaction and Molecular Dynamics Study
  28. Ligand-based pharmacophore modelling and screening of DNA minor groove binders targetingStaphylococcus aureus
  29. Molecular modeling studies and comparative analysis on structurally similar HTLV and HIV protease using HIV-PR inhibitors
  30. Interaction investigations of crustacean β-GBP recognition toward pathogenic microbial cell membrane and stimulate upon prophenoloxidase activation
  31. Virtual screening of LPXTG competitive SrtA inhibitors targeting signal transduction mechanism inBacillus anthracis: a combined experimental and theoretical study
  32. In silicoandin vitrostudies of cinnamaldehyde and their derivatives against LuxS inStreptococcus pyogenes: effects on biofilm and virulence genes
  33. Structural elucidation of SrtA enzyme in Enterococcus faecalis: an emphasis on screening of potential inhibitors against the biofilm formation
  34. A three-dimensional chemical phase pharmacophore mapping, QSAR modelling and electronic feature analysis of benzofuran salicylic acid derivatives as LYP inhibitors
  35. Investigations on the Interactions of λPhage-Derived Peptides Against the SrtA Mechanism in Bacillus anthracis
  36. Virtual screening based on pharmacophoric features of known calpain inhibitors to identify potent inhibitors of calpain
  37. Exploration of protein–protein interaction effects on α-2-macroglobulin in an inhibition of serine protease through gene expression and molecular simulations studies
  38. Validation of potential inhibitors for SrtA againstBacillus anthracisby combined approach of ligand-based and molecular dynamics simulation
  39. Identification of potential HIV-1 integrase strand transfer inhibitors:In silicovirtual screening and QM/MM docking studies
  40. Exploration of the binding of DNA binding ligands toStaphylococcalDNA through QM/MM docking and molecular dynamics simulation
  41. Shape and pharmacophore-based virtual screening to identify potential cytochrome P450 sterol 14α-demethylase inhibitors
  42. Exploration of fluoroquinolone resistance inStreptococcus pyogenes: comparative structure analysis of wild-type and mutant DNA gyrase
  43. 195In silicostudy on HIV-PRIs substructures to terminate proteolytic activity in HTLV
  44. Exploring the selectivity of a ligand complex with CDK2/CDK1: a molecular dynamics simulation approach
  45. Comparative structural analysis of two proteins belonging to quorum sensing system inVibrio cholerae
  46. Homology modeling, active site prediction, and targeting the anti hypertension activity through molecular docking on endothelin – B receptor domain
  47. Molecular docking, QPLD, and ADME prediction studies on HIV-1 integrase leads
  48. Targeting multidrug resistant Mycobacterium tuberculosis htra2 with identical chemical entities of fluoroquinolones
  49. In silico screening of indinavir-based compounds targeting proteolytic activity in HIV PR: binding pocket fit approach
  50. Pharmacophore modelling and atom-based 3D-QSAR studies onN-methyl pyrimidones as HIV-1 integrase inhibitors
  51. A database for the predicted pharmacophoric features of medicinal compounds